Hedera-22 is a biotechnology startup that specializes in providing customized bioinformatic solutions for the healthcare and biotechnology sectors. Founded in 2015, it has branched out of ULiège and is dedicated to expediting and enhancing the exploration of fresh biomolecules for medicine and agriculture. The company's unique approach merges environmental microbiology and bioinformatics, aiming to discover new biomolecules for potential applications in human medicine and agro-based industries.
HEDERA-22
Intelligent Natural Product Discovery Platform.
Founded 2015
Belgium
11 employees
Biotechnology
Belgium
11 employees
Biotechnology
General Information
Company Name
HEDERA-22
Founded Year
2015
Location
Belgium
Belgium
Employees
11
Industries
Biotechnology
Social
BounceWatch is an independent company data service, not affiliated with HEDERA-22. To contact HEDERA-22, visit hedera22.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does HEDERA-22 compare?
A PDF of HEDERA-22 and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting HEDERA-22 soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is HEDERA-22 on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
Belgium Market
Biotechnology
About HEDERA-22
Business keywords: bioinformatics, biomolecules, medicine, agriculture, microbiology, R&D, natural molecules, pharmaceutical, agronomic, innovation, biomedical, partnerships, customized solutions
No funding data available for HEDERA-22 yet.
Latest News
View All
HEDERA-22 Alternatives & Competitors
View All Alternatives
HEDERA-22 vs
A high-tech leader in gene sequencing innovation, committed to advanced clinical medicine screening...
Series C
16 employees
Biotechnology, Health Care
HEDERA-22 vs
Sutura Therapeutics Ltd
United Kingdom
A biopharmaceutical company advancing biomolecular medicine through its drug conjugate platform.
4 employees
Biotechnology, Pharmaceutical
HEDERA-22 vs
Nanomik Biotechnology
Turkey
Biochemistry leading change in life sciences.
Seed
17 employees
Biotechnology, Life Sciences
FAQ About HEDERA-22
Intelligent Natural Product Discovery Platform.
HEDERA-22 was founded in 2015.
HEDERA-22 is headquartered in Belgium.
HEDERA-22 operates in Biotechnology. Its work centres on bioinformatics, biomolecules, medicine and agriculture.
HEDERA-22 has approximately 11 employees.
Top alternatives and competitors to HEDERA-22 include 赛纳生物科技(北京)有限公司, Sutura Therapeutics Ltd, Nanomik Biotechnology, Diffuse Bio, Shanghai MediumBank Biotechnology Co., LTD.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HEDERA-22 and 赛纳生物科技(北京)有限公司 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for HEDERA-22, https://bouncewatch.com/company/hedera-22, updated 25 November 2024. When citing, please name BounceWatch and link this page.
